Inhibition of nuclear factor κB chemosensitizes non–small cell lung cancer through cytochrome c release and caspase activation
- 1 February 2002
- journal article
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 123 (2), 310-317
- https://doi.org/10.1067/mtc.2002.118684
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Inhibition of NF-κB sensitizes non–small cell lung cancer cells to chemotherapy-induced apoptosisThe Annals of Thoracic Surgery, 2000
- Mitochondrion as a Novel Target of Anticancer ChemotherapyJNCI Journal of the National Cancer Institute, 2000
- The Rel/NF-κB Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-xLMolecular and Cellular Biology, 2000
- Erratum: Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatmentNature Medicine, 1999
- Suicidal Tendencies: Apoptotic Cell Death by Caspase Family ProteinasesJournal of Biological Chemistry, 1999
- The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosisGenes & Development, 1999
- Mechanisms of apoptosis avoidance in cancerCurrent Opinion in Oncology, 1999
- The central executioners of apoptosis: caspases or mitochondria?Trends in Cell Biology, 1998
- NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 ActivationScience, 1998
- Etoposide phosphate, the water soluble prodrug of etoposideInternational Journal of Clinical Pharmacy, 1997